| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/19/2006 | CN1264848C Pyrrolo[2,1-b] [1,3] benzothiazepines and their use for preparation of medicaments with antipsychotic activity |
| 07/19/2006 | CN1264847C 1-oxa-3,9-diaza-spiro [5,5] undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 07/19/2006 | CN1264843C Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity |
| 07/19/2006 | CN1264840C 8-methoxy-(1,2,4) triazolo (1,5-A) pyridine derivatives and their use as adenosine receptor ligands |
| 07/19/2006 | CN1264838C Indole derivatives for treating central nervous system disease |
| 07/19/2006 | CN1264836C Benzoaxathiepin derivatives and their use in preparation of medicine |
| 07/19/2006 | CN1264827C 1-cyclic amino-alkylcyclohexane compounds as NMDA receptor antagonist |
| 07/19/2006 | CN1264825C Dihydro-benzo [b][1,4] diazepin-2-one derivative as mglur 2 antagonists II |
| 07/19/2006 | CN1264821C Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 07/19/2006 | CN1264576C Method and equipment for on-line preparation of dopamine transport protein developer [IIC]-beta-CFT |
| 07/19/2006 | CN1264553C Medicinal wine for quick acting and radically rheumatic arthritis and its preparing method |
| 07/19/2006 | CN1264534C Application of Compound Danshen tablet in the preparation of medicine for preventing and treating senile dementia |
| 07/19/2006 | CN1264511C Preparation and use of extracting protopine from plant |
| 07/19/2006 | CN1264502C Injection of still-freeze drying powder for restoring consciousness and new preparation method |
| 07/19/2006 | CN1264494C Method for preparing musk freeze-dried powder injection |
| 07/18/2006 | US7078565 Benzamide derivatives as antagonists of orexin receptors |
| 07/18/2006 | US7078537 Phenylalkyl diamine and amide analogs |
| 07/18/2006 | US7078529 Imidazole derivatives |
| 07/18/2006 | US7078526 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections |
| 07/18/2006 | US7078525 Antiproliferative agents; anticancer agents; antiinflammatroy agents; Alzheimer's disease; viricides; fungicides |
| 07/18/2006 | US7078521 By reaction of pyrrolobenzothiazepin-9-one with amine to give the corresponding enamine, which is subsequently transformed into the final compound |
| 07/18/2006 | US7078515 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus |
| 07/18/2006 | US7078438 N-(4 substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/18/2006 | US7078437 suppressing degradation of apolipoprotein D to prevent schizophrenia or other diseases caused by denaturation or cell damage in the nervous system, such as Alzheimer's disease, Niemann-Pick disease type C and Unverrichit-Lundborg disease by administering lauric acid or oleic acid |
| 07/18/2006 | US7078436 Administering halosubstitured phenyl alkyl carbamate compound for therapy of anxiety |
| 07/18/2006 | US7078426 Central nervous system disorders |
| 07/18/2006 | US7078423 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/18/2006 | US7078422 Activator for peroxisome proliferator-activated receptor |
| 07/18/2006 | US7078420 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 07/18/2006 | US7078417 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations |
| 07/18/2006 | US7078414 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them |
| 07/18/2006 | US7078410 4-substituted with a imidazo[1,2a]pyrid-3-yl or pyrazolo[2,3a]pyrid-3-yl ring |
| 07/18/2006 | US7078408 administering pyrimidinotriazole derivatives for improving motor impairment due to Parkinson's Disease |
| 07/18/2006 | US7078407 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them |
| 07/18/2006 | US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants |
| 07/18/2006 | US7078403 Antiviral agents |
| 07/18/2006 | US7078398 Compositions and methods for treating or preventing convulsions or seizures |
| 07/18/2006 | US7078392 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
| 07/18/2006 | US7078386 Enhancing agent for nerve growth factor production comprising a compound having a coumarin backbone or a compound having a 2-dimethyl chroman backbone |
| 07/18/2006 | US7078376 blood disorders; analgesics; nausea; cardiovascular disorders; anticancer agents; hypotensive agents; headaches; edema; diarrhea; thrombosis; reducing dosage |
| 07/18/2006 | US7078230 Adipose tissue-derived stromal cell that expresses characteristics of a neuronal cell |
| 07/18/2006 | US7078217 Aggrecanase molecules |
| 07/18/2006 | US7078186 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of tumor disorders |
| 07/18/2006 | US7078177 Identifying modulators of oncogene receptor binding activity for treating pain, neuropathic and inflammatory, learning and memory, anxiety and cardiovascular disorders |
| 07/18/2006 | US7078173 Assays and therapies for latent viral infection |
| 07/18/2006 | US7078065 Plant extracts; adjustment pH with acid; prevention brain damage |
| 07/18/2006 | US7078057 Heating with carrier; mixtur eof fine and coarse particle sizes |
| 07/18/2006 | US7078053 Ibuprofen composition |
| 07/18/2006 | US7078052 Enhanced absorption and bioavailability |
| 07/18/2006 | US7078020 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
| 07/18/2006 | US7078019 Heating a drug ester to vaporize; cooling to form condensation aerosol; drug delivery kit for dispensing thin coatings |
| 07/18/2006 | US7078018 Aerosol therapy; heating, vaporization, cooling, condensation; analgesics; alcoholism |
| 07/18/2006 | US7078017 Delivery of sedative-hypnotics through an inhalation route |
| 07/18/2006 | CA2351833C New cyclopropanic compounds, 1,1 and 1,2-disubstitute, their preparation process and pharmaceutical compositions containing them |
| 07/18/2006 | CA2309771C New substitute dimeric derivatives, their preparation process and the pharmaceutical compositions that contain them |
| 07/18/2006 | CA2224528C Stilbene compositions in the adamantyl group, compositions containing them and uses |
| 07/13/2006 | WO2006074387A1 Methods for the treatment of lysosomal storage disorders |
| 07/13/2006 | WO2006074025A1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 07/13/2006 | WO2006073886A1 Olanzapine pamoate dihydrate |
| 07/13/2006 | WO2006073729A1 Oral disintegrating dosage forms |
| 07/13/2006 | WO2006073367A1 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver x receptor modulators |
| 07/13/2006 | WO2006073366A1 Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | WO2006073365A1 Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | WO2006073364A1 Derivatives of isothiazol-3 (2h)-thione 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | WO2006073363A1 Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | WO2006073360A1 NEW USE OF 11-PIPERAZIN-1-YLDIBENZO [b,f] [1,4] THIAZEPINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND TO ORAL PHARMACEUTICAL COMPOSITIONS |
| 07/13/2006 | WO2006073265A1 Composition comprising an extract of gramineae plant for the prevention and treatment of ischemic diseases and degenerative brain diseases and the use thereof |
| 07/13/2006 | WO2006073197A1 1-thio-d-glucitol derivatives |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |
| 07/13/2006 | WO2006072957A1 Anti-arrythmic drugs and cholesterol absorption inhibitors as neuroprotective agents for the treatment of neurodegenerative and autoimmune disorders |
| 07/13/2006 | WO2006072881A1 Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
| 07/13/2006 | WO2006072878A1 Oral dosage forms of sertraline having controlled particle size and processes for their preparation |
| 07/13/2006 | WO2006072832A1 Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 07/13/2006 | WO2006072792A2 Compounds which bind to the active site of protein kinase enzymes |
| 07/13/2006 | WO2006072732A1 Use of cyproterone acetate for treating aggressive behaviours in patients suffering from dementia |
| 07/13/2006 | WO2006072588A1 Substituted 2-amino-quinazolin-4-cn compounds for use in the treatment of cns disorders, pain, stroke, addiction and epilepsy, their preaparation and use as intermediates |
| 07/13/2006 | WO2006072436A1 [4-(heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 07/13/2006 | WO2006072435A1 Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 07/13/2006 | WO2006072432A1 Benzoyl-tetrahydropyridine as glyt-1 inhibitors |
| 07/13/2006 | WO2006072430A1 Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists |
| 07/13/2006 | WO2006072413A1 Use of selected cgrp antagonists in combination with other antimigraine medical substances for the treatment of migraine |
| 07/13/2006 | WO2006072213A1 Anti-depression formulations |
| 07/13/2006 | WO2006032879A3 Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc) |
| 07/13/2006 | WO2006026555A3 Neuroprotective effect of solubilized udca in focal ischemic model |
| 07/13/2006 | WO2006008003A3 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1) |
| 07/13/2006 | WO2005077416A3 Lipid rafts and clostridial toxins |
| 07/13/2006 | WO2004078908A3 Alpha-keto carbonyl calpain inhibitors |
| 07/13/2006 | US20060154984 Therapeutic use of acyl glycerols and the nitrogen- and sulphur- containing analogues thereof |
| 07/13/2006 | US20060154977 Therapeutic molecules and methods-1 |
| 07/13/2006 | US20060154972 Amino acids with affinity for the alpha-2-delta-protein |
| 07/13/2006 | US20060154969 Adenosine receptor selective modulators |
| 07/13/2006 | US20060154963 Phosphatase and Tensin homolog deleted on chromosome Ten (PTEN), a tumor suppressor gene or calcium sensitive potassium channel modulators, comprising tetrazolylalkoxy-dihydrocarbostyril compounds such as Cilostazol , used for the treatment of Alzheimer's disease |
| 07/13/2006 | US20060154945 e.g. (R)-3'-(5-phenyl-thiophen-2-yl)spiro[1-azabicyclo[2.2.2]octan-3,5'-oxazolidin]-2'-one; nicotinic acetylcholine receptor agonist; antidepressant, neurodegenerative diseses; Alzheimer's disease, cognitive or attention disorders, smoking cessation, schizophrenia, analgesia |
| 07/13/2006 | US20060154944 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 07/13/2006 | US20060154938 Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
| 07/13/2006 | US20060154933 Inhibitors of Cdc25 phosphatases |
| 07/13/2006 | US20060154930 Substituted amino heterocycles as vr-1 antagonists for treating pain |
| 07/13/2006 | US20060154929 Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds |
| 07/13/2006 | US20060154922 Muscarinic agonists |
| 07/13/2006 | US20060154920 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij] quinoline derivatives as antipsychotic and antiobesity agents |